|
2024
|
Invention
|
Novel compounds as modulators of il17. The present invention relates to novel compounds of genera... |
|
|
Invention
|
Amorphous form of resmetirom and process for preparation thereof.
The present invention relates ... |
|
|
Invention
|
Novel compounds to treat viral infections. The present invention relates to novel compounds of th... |
|
|
Invention
|
Treatment for amyotrophic lateral sclerosis (als). Present invention relates to the development o... |
|
|
Invention
|
Protein based chimeric vaccine for dyslipidemia & atherosclerosis. The present invention provides... |
|
|
Invention
|
Sacituzumab drug conjugates and preparation thereof. The invention provides antibody-linker-drug ... |
|
|
Invention
|
Daratumumab drug conjugates and preparation thereof. The invention provides antibody-linker-drug ... |
|
|
Invention
|
Process for the preparation of sitagliptin free from genotoxic impurities.
The present invention... |
|
|
Invention
|
Treatment for inflammatory bowel disease. The present invention relates to the development of the... |
|
|
Invention
|
Novel atx inhibitors. The present invention relates to compounds of the general formula (I) their... |
|
|
Invention
|
Gastroretentive extended release compositions of riociguat. The present invention provides gastro... |
|
2023
|
Invention
|
Fc variants and preparation thereof. The present invention relates to FcRn-antagonist or Fc varia... |
|
|
Invention
|
Extended-release pharmaceutical compositions of dydrogestrone. The present invention relates to a... |
|
|
Invention
|
Pharmaceutical compositions of sitagliptin.
The present invention relates to stable oral pharmac... |
|
|
Invention
|
Novel compounds for the treatment of mammalian infections. The present invention provides novel c... |
|
|
Invention
|
Improved process for the preparation of sulfonylurea based compounds. The present invention relat... |
|
|
G/S
|
Medicinal and pharmaceutical preparations. |
|
|
G/S
|
Medicinal and pharmaceutical preparations. |
|
|
Invention
|
Heterobicyclic compounds as oral glp1r agonists. The present invention discloses novel compounds ... |
|
|
Invention
|
Treatment for aplastic anemia (aa). The present invention describes a combination of a suitable p... |
|
|
Invention
|
Treatment for glomerular diseases. The present invention relates to the development of therapeuti... |
|
|
Invention
|
Reusable multi-dose, variable dose, single pen injector for type 2 diabetes and weight management... |
|
|
Invention
|
Lyophilized pharmaceutical compositions of copper histidinate. The present invention relates to l... |
|
|
Invention
|
Lyophilized pharmaceutical compositions of copper histidinate.
The present invention relates to ... |
|
|
Invention
|
Treatment for primary biliary cholangitis. The present invention provides therapeutic compound fo... |
|
|
Invention
|
Novel compounds to treat cytokine related disorders. The present invention relates to novel compo... |
|
|
Invention
|
Pharmaceutical compositions comprising a β-blocker and an sglt2 inhibitor. The invention relates ... |
|
2022
|
Invention
|
Pharmaceutical combinations.
Present invention relates to combination of Apremilast or pharmaceu... |
|
|
Invention
|
Pharmaceutical combinations. Present invention relates to combination of Apremilast or pharmaceut... |
|
|
Invention
|
Desidustat particles and compositions thereof.
This invention relates to a field of pharmaceutic... |
|
|
Invention
|
Desidustat particles and compositions thereof. This invention relates to a field of pharmaceutica... |
|
|
Invention
|
An amorphous solid dispersion of a quinolone compound and process for the preparation thereof.
T... |
|
|
Invention
|
An amorphous solid dispersion of a quinolone compound and process for the preparation thereof. Th... |
|
|
Invention
|
Treatment for neuroinflammatory disorders. The present invention relates to the development of th... |
|
|
Invention
|
Pharmaceutical formulations of tnf-alpha antibodies.
The present invention provides certain impr... |
|
|
Invention
|
Stable pharmaceutical compositions of apomorphine.
The present invention provides a stable pharm... |
|
|
Invention
|
Stable pharmaceutical compositions of apomorphine. The present invention provides a stable pharma... |
|
|
Invention
|
Pharmaceutical compositions of ozanimod.
The present invention relates to pharmaceutical composi... |
|
|
Invention
|
Pharmaceutical compositions of ozanimod. The present invention relates to pharmaceutical composit... |
|
|
Invention
|
A quinolone compound in solid forms and processes for the preparation thereof.
The present inven... |
|
|
Invention
|
Treatment of sickle cell anaemia.
Present invention relates to development of compound of formul... |
|
2021
|
Invention
|
Treatment for the inflammatory bowel disease.
Present invention relates to development of compou... |
|
|
Invention
|
Treatment for psoriasis and skin inflammatory diseases.
Present invention relates to development... |
|
|
Invention
|
Fc variant and preparation thereof.
The present invention relates to Fc variant protein and prep... |
|
|
Invention
|
A vaccine against sars-cov-2 and preparation thereof.
The current invention provides a DNA const... |
|
|
Invention
|
Formulation comprising hif prolyl hydroxylase inhibitors.
The present invention generally relate... |
|
|
Invention
|
Novel subtituted sulfonylurea and sulfoximineurea derivatives.
The present invention relates to ... |
|
|
Invention
|
Anti-properdin antibodies and preparation thereof.
The present invention provides an antibody or... |
|
2020
|
Invention
|
Novel compounds suitable for the treatment of dyslipidemia.
The present invention relates to com... |
|
2013
|
G/S
|
Chemical preparations for treating phylloxera; deodorizers and air purifiers, air purifying prepa... |
|
|
G/S
|
Medicinal and pharmaceutical preparations. |
|
|
G/S
|
Medicinal and Pharmaceutical Preparations. |
|
2003
|
G/S
|
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and ab... |
